Microscopic Hematuria (2020 AUA Guidelines): Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 42: | Line 42: | ||
== Diagnosis and Evaluation == | == Diagnosis and Evaluation == | ||
=== Risk stratification === | === <span style="color:#ff0000">Risk stratification</span> === | ||
* '''<span style="color:#ff0000">Factors to consider (5):</span>''' | * '''<span style="color:#ff0000">Factors to consider (5):</span>''' | ||
| Line 90: | Line 90: | ||
|} | |} | ||
* '''Recommended investigations based on risk stratification (4)''' | * '''<span style="color:#ff0000">Recommended investigations based on risk stratification (4)</span>''' | ||
*# ''' | *# '''<span style="color:#ff0000">History and Physical Exam (all patients)</span>''' | ||
*# '''Laboratory: serum Cr and GFR (all patients); urine cytology or other markers are not recommended''' | *# '''<span style="color:#ff0000">Laboratory: serum Cr and GFR (all patients);</span> urine cytology or other markers are not recommended''' | ||
*# '''Imaging: upper tract imaging''' '''(intermediate, high-risk, and if family history of RCC or other genetic renal tumor syndrome)''' | *# '''<span style="color:#ff0000">Imaging: upper tract imaging''' '''(intermediate, high-risk, and if family history of RCC or other genetic renal tumor syndrome)</span>''' | ||
*#* '''US for intermediate-risk''' | *#* '''<span style="color:#ff0000">US for intermediate-risk</span>''' | ||
*#* '''CT urography for high-risk''' | *#* '''<span style="color:#ff0000">CT urography for high-risk</span>''' | ||
*# '''Cystoscopy (intermediate and high-risk)''' | *# '''<span style="color:#ff0000">Cystoscopy (intermediate and high-risk)</span>''' | ||
* | * | ||
** '''History and | ** '''History and Physical Exam''' | ||
*** '''History''' | *** '''History''' | ||
**** '''Risk factors for malignancy (12):''' | **** '''Risk factors for malignancy (12):''' | ||